Mizuho Securities USA’s Medicus Sciences Acquisition Corp. Class A Ordinary Share MSAC Stock Holding History

Mizuho Securities USA’s Portfolio MSAC Stock Details MSAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-321,898	Closed	-$3.2M	–	234
2022 Q4	$3.2M	Buy	321,898 +59,031	+22%	+$589K	0.3%	61
2022 Q3	$2.59M	Buy	+262,867	New	+$2.59M	0.35%	95

Mizuho Securities USA's MSAC Position: Q1 2023 in Review

Mizuho Securities USA sold out of Medicus Sciences Acquisition Corp. Class A Ordinary Share (MSAC) in Q1 2023, closing a stake of 321,898 shares — an estimated $3.2M sold.

Mizuho Securities USA first reported a position in MSAC in Q3 2022 and held it in 2 quarters. The position peaked at $3.2M in Q4 2022. 0 funds tracked by Wall St. Rank hold MSAC as of Q1 2023.

Mizuho Securities USA reported no remaining Medicus Sciences Acquisition Corp. Class A Ordinary Share position as of Q1 2023 after selling out during the quarter.
Mizuho Securities USA sold 321,898 Medicus Sciences Acquisition Corp. Class A Ordinary Share shares in Q1 2023, an estimated $3.2M.
Mizuho Securities USA first reported a position in Medicus Sciences Acquisition Corp. Class A Ordinary Share in Q3 2022 and held it in 2 quarters.
Mizuho Securities USA's Medicus Sciences Acquisition Corp. Class A Ordinary Share position peaked at $3.2M in Q4 2022.
0 funds tracked by Wall St. Rank held Medicus Sciences Acquisition Corp. Class A Ordinary Share as of Q1 2023.

Based on Mizuho Securities USA's 13F filing for Q1 2023, filed 3 May 2023.